EYPT Bathi resik saben saham (EPS TTM) EyePoint Pharmaceuticals

EyePoint Pharmaceuticals management strictly adheres to environmental regulations regarding reagent disposal. The 12-month net income per share trend on GURU.Markets captures the results of developing sustained-release drug delivery systems and expanding a network of specialized laboratories to maintain margins. The current -3.76 metric reflects the efficiency dynamics of these proprietary technologies and supply chains.

EYPT Bathi resik saben saham sajrone patang kuartal pungkasan EyePoint Corp (04.07.2022 - 11.11.2026)

Rincian analitis lan laporan data perusahaan EyePoint Pharmaceuticals Inc (EYPT)

- rega saham lan prakiraan rega para ahli:

Kutipan saham EyePoint Pharmaceuticals|EYPT - Rata-rata rega prakiraan

- data kapitalisasi pasar:

Kapitalisasi pasar EyePoint Pharmaceuticals, Inc.|EYPT - Total Nilai Perusahaan

- rincian valuasi buku bisnis:

Aset Bersih saben Siji Saham EyePoint Pharmaceuticals|EYPT - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku eyepointpharma.com|EYPT - Aset Perusahaan

- rincian utang lan likuiditas:

Rasio Total Utang marang Ekuitas EyePoint Pharmaceuticals|EYPT - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal EyePoint Pharma|EYPT - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku EyePoint Pharmaceuticals, Inc.|EYPT - Kewajiban jangka dawa|Utang jangka cendhak perusahaan EyePoint Pharmaceuticals|Rasio cepet eyepointpharma.com

- data bathi lan kelipatan valuasi:

EYPT - Asil keuangan resik|Bathi sing dikarepake EyePoint Pharmaceuticals|EYPT - Pangali rega marang bathi|Prakiraan rega marang bathi EyePoint Pharmaceuticals, Inc.|EYPT - Rasio nilai perusahaan marang wutah bathi|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan EyePoint Pharmaceuticals, Inc.|EYPT - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan EyePoint Pharmaceuticals|EYPT - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan eyepointpharma.com|EYPT - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep EyePoint Pharmaceuticals

Analisis dhasar perusahaan:EYPT - EyePoint Pharmaceuticals

Barang unggulan EyePoint Pharmaceuticals Inc

This metric reflects the net income of EyePoint Pharmaceuticals (EYPT) allocated per common share over the last twelve months, allowing for an assessment of the business's real profitability without accounting for capital dilution. By analyzing the trailing twelve-month earnings per share, an investor can gauge the efficiency of the commercialization of ophthalmologic implants under the guidance of experienced experts, where the stability of the metric confirms the resilience of the market entry strategy for its drugs.

Pesaing wigati